TrianglePUBLICATIONS · 8523058
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1995 Dec
- First author
- Moertel CG
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Moertel CG
- type
- Author
- name
- Fleming TR
- type
- Author
- name
- Macdonald JS
- type
- Author
- name
- Haller DG
- type
- Author
- name
- Laurie JA
- type
- Author
- name
- Tangen CM
- type
- Author
- name
- Ungerleider JS
- type
- Author
- name
- Emerson WA
- type
- Author
- name
- Tormey DC
- type
- Author
- name
- Glick JH
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Moertel CG
- type
- Author
- name
- Fleming TR
- type
- Author
- name
- Macdonald JS
- type
- Author
- name
- Haller DG
- type
- Author
- name
- Laurie JA
- type
- Author
- name
- Tangen CM
- type
- Author
- name
- Ungerleider JS
- type
- Author
- name
- Emerson WA
- type
- Author
- name
- Tormey DC
- type
- Author
- name
- Glick JH
- type
- Author
- bibliography ids
- nci-bib-c9a73beb18516e90300274ee
- book metadata
- content sha256
- f38ead503724683fd2ba6782bb0bb3372b4d4c9d3b21d79ddde03bb5e7cbe231
- document type
- citation
- dois
- 10.1200/JCO.1995.13.12.2936
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8523058
- immutable id
- pubmed:8523058@f38ead503724683fd2ba6782bb0bb3372b4d4c9d3b21d79ddde03bb5e7cbe231
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 12
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2936-43
- volume
- 13
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8523058
- provenance
- batch id
- 6de860041cedd40f623b
- provider
- NCBI PubMed ESummary
- record sha256
- cfbc44eb16aa6b85725326310d5669c75f94ba754983d3c633e08ca79cf5831c
- response sha256
- f46103bbddb69bd5f2ea5fd2e8d9cab75a19eeb01ce2a0d1f98b4d456a872039
- retrieved at
- 2026-09-09T23:45:23.163950+00:00
- publication date
- display
- 1995 Dec
- precision
- month
- year
- 1995
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8523058/
- title
- Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
Preserved source evidence · Not medical advice